{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:15:27Z","timestamp":1788020127304,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Beh\u00e7et disease (BD) is a debilitating multi-systemic vasculitis with a litany of muco-cutaneous manifestations and potentially lethal complications. Meanwhile, psoriasis (PSO) is a cutaneous and systemic inflammatory disorder marked by hyperplastic epidermis and silvery scales, which may be accompanied by a distinct form of arthropathy called psoriatic arthritis (PsA). While the clinical pictures of these two are quite different, they feature some important similarities, most of which may stem from the autoinflammatory components of BD and PSO. Therefore, the aim of this study was to investigate the prospective link between BD and cutaneous and articular manifestations of psoriasis. BD, PSO, and PsA cohorts were extracted using the National Health Insurance Service of Korea database. Using\n                    <jats:italic>\u03c7<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    tests, prevalence of PSO and PsA with respect to BD status was analysed. Relative to non-BD individuals, those with personal history of BD were nearly three times more likely to be diagnosed with PSO. The adjusted odds ratio (aOR) was 2.36 [95% confidence interval (CI), 1.91\u20132.93,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001]. Elevated PSO risk was more pronounced in the male BD cohort (aOR\u2009=\u20091.19, 95% CI 1.16\u20131.23,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). In age-group sub-analysis, individuals over 65\u00a0years with PSO were one and a half times more likely to be affected with BD, relative to those under 65. The adjusted OR for the older group was 1.51 (95% CI 1.43\u20131.59,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). BD individuals with \u201chealthy\u201d body weight were significantly\n                    <jats:italic>less<\/jats:italic>\n                    likely to be affected by PSO (aOR\u2009=\u20090.59, 95% CI 0.57\u20130.62,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). On the other hand, there was a correlation between BMI and the risk of BD, with the \u201cmoderately obese (30\u201335\u00a0kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    )\u201d group having an aOR of 1.24 (95% CI 1.12\u20131.38,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). BD patients were also twice more likely to be associated with PsA (aOR\u2009=\u20092.19, 95% CI 1.42\u20133.38,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). However, in contrast to the case of psoriatic disease itself, females were exposed to a greater risk of developing BD compared to the male PsA cohort (aOR\u2009=\u20092.02, 95% CI 1.88\u20132.16,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). As with PSO, older BD patients were exposed to a significantly higher risk of developing PsA (aOR\u2009=\u20093.13, 95% CI 2.90\u20133.40,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Beh\u00e7et disease may place an individual at a significantly increased risk of psoriasis, and still greater hazard of being affected with psoriatic arthritis. This added risk was pronounced in the male cohort, and tended to impact senile population, and this phenomenon may be related with the relatively poor prognosis of BD in males and PSO in older patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-81972-4","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T06:04:39Z","timestamp":1611813879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of Beh\u00e7et disease with psoriasis and psoriatic arthritis"],"prefix":"10.1038","volume":"11","author":[{"given":"Hyung Jin","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gyu","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Yeup","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"issue":"9","key":"81972_CR1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1136\/bjo.87.9.1175","volume":"87","author":"DH Verity","year":"2003","unstructured":"Verity, D. H., Wallace, G. R., Vaughan, R. W. & Stanford, M. R. Beh\u00e7et\u2019s disease: from Hippocrates to the third millennium. Br. J. Ophthalmol. 87(9), 1175\u20131183 (2003).","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"81972_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00296-019-04261-4","volume":"39","author":"LI Sakkas","year":"2019","unstructured":"Sakkas, L. I. & Tronzas, P. The Greek (Hellenic) rheumatology over the years: from ancient to modern times. Rheumatol. Int. 39(6), 947\u2013955 (2019).","journal-title":"Rheumatol. Int."},{"issue":"10","key":"81972_CR3","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s00415-017-8436-9","volume":"264","author":"DP Kidd","year":"2017","unstructured":"Kidd, D. P. Neurological complications of Beh\u00e7et\u2019s syndrome. J. Neurol. 264(10), 2178\u20132183 (2017).","journal-title":"J. Neurol."},{"issue":"5","key":"81972_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.berh.2008.08.005","volume":"22","author":"S Yurdakul","year":"2008","unstructured":"Yurdakul, S. & Yazici, H. Behcet\u2019s syndrome. Best Pract. Res. Clin.. Rheumatol. 22(5), 793\u2013809 (2008).","journal-title":"Best Pract. Res. Clin.. Rheumatol."},{"issue":"5","key":"81972_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1076\/opep.9.5.325.10338","volume":"9","author":"A Idil","year":"2002","unstructured":"Idil, A. et al. The prevalence of Behcet\u2019s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol. 9(5), 325\u2013331 (2002).","journal-title":"Ophthalmic Epidemiol."},{"issue":"1","key":"81972_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13317-016-0074-1","volume":"7","author":"MJ Zeidan","year":"2016","unstructured":"Zeidan, M. J., Saadoun, D. & Garrido, M. Beh\u00e7et\u2019s disease physiopathology: a contemporary review. Auto Immun. Highlights 7(1), 4 (2016).","journal-title":"Auto Immun. Highlights"},{"issue":"1","key":"81972_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41598-017-00877-3","volume":"7","author":"K Yamazoe","year":"2017","unstructured":"Yamazoe, K. et al. Comprehensive analysis of the association between UBAC2 polymorphisms and Beh\u00e7et\u2019s disease in a Japanese population. Sci. Rep. 7(1), 742 (2017).","journal-title":"Sci. Rep."},{"key":"81972_CR8","doi-asserted-by":"publisher","first-page":"39850","DOI":"10.1038\/srep39850","volume":"7","author":"SW Kim","year":"2017","unstructured":"Kim, S. W. et al. Identification of genetic susceptibility loci for intestinal Beh\u00e7et\u2019s disease. Sci. Rep. 7, 39850 (2017).","journal-title":"Sci. Rep."},{"issue":"8","key":"81972_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.autrev.2017.05.021","volume":"16","author":"C Comarmond","year":"2017","unstructured":"Comarmond, C. & Cacoub, P. Myocarditis in auto-immune or auto-inflammatory diseases. Autoimmun. Rev. 16(8), 811\u2013816 (2017).","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"81972_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jbspin.2018.11.003","volume":"86","author":"I Kone-Paut","year":"2019","unstructured":"Kone-Paut, I. et al. New data in causes of autoinflammatory diseases. Joint Bone Spine 86(5), 554\u2013561 (2019).","journal-title":"Joint Bone Spine"},{"issue":"12","key":"81972_CR11","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/rheumatology\/key242","volume":"57","author":"Y Ozguler","year":"2018","unstructured":"Ozguler, Y. et al. Management of major organ involvement of Beh\u00e7et\u2019s syndrome: a systematic review for update of the EULAR recommendations. Rheumatol. (Oxf.) 57(12), 2200\u20132212 (2018).","journal-title":"Rheumatol. (Oxf.)"},{"issue":"1","key":"81972_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000018426","volume":"201","author":"J Katsantonis","year":"2000","unstructured":"Katsantonis, J. et al. Adamantiades-Beh\u00e7et\u2019s disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201(1), 37\u201339 (2000).","journal-title":"Dermatology"},{"issue":"3","key":"81972_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","volume":"48","author":"SP Durmazlar","year":"2009","unstructured":"Durmazlar, S. P., Ulkar, G. B., Eskioglu, F. & Zouboulis, C. C. Significance of serum interleukin-8 levels in patients with Beh\u00e7et\u2019s disease: high levels may indicate vascular involvement. Int. J. Dermatol. 48(3), 259\u2013264 (2009).","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"81972_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2230.2008.02811.x","volume":"34","author":"M Polat","year":"2009","unstructured":"Polat, M. et al. Classifying patients with Beh\u00e7et\u2019s disease for disease severity, using a discriminating analysis method. Clin. Exp. Dermatol. 34(2), 151\u2013155 (2009).","journal-title":"Clin. Exp. Dermatol."},{"key":"81972_CR15","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3389\/fimmu.2019.01085","volume":"10","author":"G Emmi","year":"2019","unstructured":"Emmi, G., Becatti, M., Bettiol, A. & Eksioglu, M. Beh\u00e7et\u2019s syndrome as a model of thrombo-inflammation: the role of neutrophils. Front Immunol. 10, 1085 (2019).","journal-title":"Front Immunol."},{"issue":"1","key":"81972_CR16","doi-asserted-by":"publisher","first-page":"11714","DOI":"10.1038\/s41598-019-48046-y","volume":"9","author":"M Vranova","year":"2019","unstructured":"Vranova, M. et al. Opposing roles of endothelial and leukocyte-expressed IL-7R\u03b1 in the regulation of psoriasis-like skin inflammation. Sci. Rep. 9(1), 11714 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"81972_CR17","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1038\/s41598-019-47774-5","volume":"9","author":"E Sz\u00e9l","year":"2019","unstructured":"Sz\u00e9l, E. et al. Comprehensive proteomic analysis reveals intermediate stage of non-lesional psoriatic skin and points out the importance of proteins outside this trend. Sci. Rep. 9(1), 11382 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"81972_CR18","doi-asserted-by":"publisher","first-page":"10870","DOI":"10.1038\/s41598-019-47310-5","volume":"9","author":"M Diani","year":"2019","unstructured":"Diani, M. et al. Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis. Sci. Rep. 9(1), 10870 (2019).","journal-title":"Sci. Rep."},{"issue":"3","key":"81972_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.det.2013.04.009","volume":"31","author":"JJ Rivas Bejarano","year":"2013","unstructured":"Rivas Bejarano, J. J. & Valdecantos, W. C. Psoriasis as autoinflammatory disease. Dermatol. Clin. 31(3), 445\u2013460 (2013).","journal-title":"Dermatol. Clin."},{"issue":"5","key":"81972_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000449526","volume":"232","author":"AS Murthy","year":"2016","unstructured":"Murthy, A. S. & Leslie, K. Autoinflammatory skin disease: a review of concepts and applications to general dermatology. Dermatology 232(5), 534\u2013540 (2016).","journal-title":"Dermatology"},{"issue":"2","key":"81972_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jdermsci.2018.01.012","volume":"90","author":"M Akiyama","year":"2018","unstructured":"Akiyama, M., Takeichi, T. & McGrath, J. A. Autoinflammatory keratinization diseases: an emerging concept encompassing various inflammatory keratinization disorders of the skin. J. Dermatol. Sci. 90(2), 105\u2013111 (2018).","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"81972_CR22","doi-asserted-by":"publisher","first-page":"15783","DOI":"10.1038\/s41598-018-34173-5","volume":"8","author":"T Oike","year":"2018","unstructured":"Oike, T. et al. IL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouse. Sci. Rep. 8(1), 15783 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"81972_CR23","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1038\/s41598-018-22409-3","volume":"8","author":"T Takahashi","year":"2018","unstructured":"Takahashi, T. et al. Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors. Sci. Rep. 8(1), 4032 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"81972_CR24","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41598-019-39113-5","volume":"9","author":"S Burillo-Sanz","year":"2019","unstructured":"Burillo-Sanz, S. et al. Beh\u00e7et\u2019s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes. Sci. Rep. 9(1), 2777 (2019).","journal-title":"Sci. Rep."},{"issue":"12","key":"81972_CR25","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"H Direskeneli","year":"2006","unstructured":"Direskeneli, H. Autoimmunity versus autoinflammation in Behcet\u2019s disease: do we oversimplify a complex disorder?. Rheumatol. (Oxf.) 45(12), 1461\u20131465 (2006).","journal-title":"Rheumatol. (Oxf.)"},{"key":"81972_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","volume":"49","author":"Y Liang","year":"2017","unstructured":"Liang, Y., Sarkar, M. K., Tsoi, L. C. & Gudjonsson, J. E. Psoriasis: a mixed autoimmune and autoinflammatory disease. Curr. Opin. Immunol. 49, 1\u20138 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"81972_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08830189709116840","volume":"14","author":"H Yaz\u0131c\u0131","year":"1997","unstructured":"Yaz\u0131c\u0131, H. The place of Behcet\u2019s Syndrome among the autoimmune diseases. Intern. Rev. Immunol. 14, 1\u201310 (1997).","journal-title":"Intern. Rev. Immunol."},{"issue":"4","key":"81972_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","volume":"37","author":"A G\u00fcl","year":"2015","unstructured":"G\u00fcl, A. Pathogenesis of Beh\u00e7et\u2019s disease: autoinflammatory features and beyond. Semin. Immunopathol. 37(4), 413\u2013418 (2015).","journal-title":"Semin. Immunopathol."},{"issue":"10","key":"81972_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"M de Pineton Chambrun","year":"2012","unstructured":"de Pineton Chambrun, M., Wechsler, B., Geri, G., Cacoub, P. & Saadoun, D. New insights into the pathogenesis of Beh\u00e7et\u2019s disease. Autoimmun. Rev. 11(10), 687\u2013698 (2012).","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"81972_CR30","doi-asserted-by":"publisher","first-page":"17612","DOI":"10.1038\/s41598-018-35700-0","volume":"8","author":"M Mahmoudi","year":"2019","unstructured":"Mahmoudi, M. et al. Epistatic interaction of ERAP1 and HLA-B*51 in Iranian patients with Beh\u00e7et\u2019s disease. Sci. Rep. 8(1), 17612 (2019).","journal-title":"Sci. Rep."},{"issue":"2","key":"81972_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.smim.2016.03.004","volume":"28","author":"N Thieblemont","year":"2016","unstructured":"Thieblemont, N., Wright, H. L., Edwards, S. W. & Witko-Sarsat, V. Human neutrophils in auto-immunity. Semin. Immunol. 28(2), 159\u2013173 (2016).","journal-title":"Semin. Immunol."},{"issue":"1","key":"81972_CR32","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1111\/j.1468-3083.2012.04559.x","volume":"27","author":"S Cho","year":"2013","unstructured":"Cho, S., Cho, S. B., Choi, M. J., Zheng, Z. & Bang, D. Beh\u00e7et\u2019s disease in concurrence with psoriasis. J. Eur. Acad. Dermatol. Venereol. 27(1), e113\u2013e118 (2013).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"9583","key":"81972_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths, C. E. & Barker, J. N. Pathogenesis and clinical features of psoriasis. Lancet 370(9583), 263\u2013271 (2007).","journal-title":"Lancet"},{"issue":"1","key":"81972_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/rheumatology\/kew486","volume":"57","author":"C Maldini","year":"2018","unstructured":"Maldini, C., Druce, K., Basu, N., LaValley, M. P. & Mahr, A. Exploring the variability in Beh\u00e7et\u2019s disease prevalence: a meta-analytical approach. Rheumatol. (Oxf.) 57(1), 185\u2013195 (2018).","journal-title":"Rheumatol. (Oxf.)"},{"issue":"2","key":"81972_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5152\/eurjrheum.2017.160095","volume":"4","author":"SS Koca","year":"2017","unstructured":"Koca, S. S. et al. Low prevalence of obesity in Beh\u00e7et\u2019s disease is associated with high obestatin level. Eur. J. Rheumatol. 4(2), 113\u2013117 (2017).","journal-title":"Eur. J. Rheumatol."},{"key":"81972_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1385\/ENDO:29:1:109","volume":"29","author":"GA Bray","year":"2006","unstructured":"Bray, G. A. & Bellanger, T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29, 109\u2013117 (2006).","journal-title":"Endocrine"},{"issue":"4","key":"81972_CR37","first-page":"S118","volume":"25","author":"A Oguz","year":"2007","unstructured":"Oguz, A., Dogan, E. G., Uzunlulu, M. & Oguz, F. M. Insulin resistance and adiponectin levels in Beh\u00e7et\u2019s syndrome. Clin. Exp. Rheumatol. 25(4), S118\u2013S119 (2007).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"81972_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40257-013-0034-8","volume":"14","author":"B Yal\u00e7\u0131n","year":"2013","unstructured":"Yal\u00e7\u0131n, B., G\u00fcr, G., Art\u00fcz, F. & Alli, N. Prevalence of metabolic syndrome in Beh\u00e7et disease: a case-control study in Turkey. Am. J. Clin. Dermatol. 14(5), 421\u2013425 (2013).","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"81972_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/ije\/dyu045","volume":"43","author":"MC Harps\u00f8e","year":"2014","unstructured":"Harps\u00f8e, M. C. et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int. J. Epidemiol. 43(3), 843\u2013855 (2014).","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"81972_CR40","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1038\/s41598-019-40658-8","volume":"9","author":"HJ Hahn","year":"2019","unstructured":"Hahn, H. J., Kwak, S. G., Kim, D. K. & Kim, J. Y. A nationwide, population-based cohort study on potential autoimmune Association of M\u00e9ni\u00e8re Disease to Atopy and Vitiligo. Sci. Rep. 9(1), 4406 (2019).","journal-title":"Sci. Rep."},{"key":"81972_CR41","doi-asserted-by":"publisher","first-page":"c5623","DOI":"10.1136\/bmj.c5623","volume":"341","author":"AD Burden","year":"2010","unstructured":"Burden, A. D. et al. Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance. BMJ 341, c5623 (2010).","journal-title":"BMJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81972-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81972-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81972-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T21:45:35Z","timestamp":1670017535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81972-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["81972"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-81972-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"13 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2531"}}